ABO-Incompatible Kidney Transplantation Using Antigen-Specific Immunoadsorption and Rituximab: A 3-Year Follow-up | Zendy

Helena Genberg | Zendy; Gunilla Kumlien | Zendy; Lars Wennberg | Zendy; Ulla Berg | Zendy; Gunnar Tydén | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

ABO-Incompatible Kidney Transplantation Using Antigen-Specific Immunoadsorption and Rituximab: A 3-Year Follow-up

Author(s) -

Helena Genberg,

Gunilla Kumlien,

Lars Wennberg,

Ulla Berg,

Gunnar Tydén

Publication year - 2008

Publication title -

transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.45

H-Index - 204

eISSN - 1534-6080

pISSN - 0041-1337

DOI - 10.1097/tp.0b013e3181726849

Subject(s) - immunoadsorption , medicine , kidney transplantation , rituximab , abo blood group system , renal function , transplantation , urology , panel reactive antibody , kidney , creatinine , gastroenterology , surgery , immunology , antibody

In 2001 a protocol for ABO-incompatible (ABOi) kidney transplantation based on antigen-specific immunoadsorption and rituximab was introduced at our center, short-term results being comparable with those of ABO-compatible (ABOc) living donor kidney transplantation. Of greater importance, however, is long-term graft function, thus far not evaluated. The aim of this study was therefore to assess long-term results of this protocol.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research